Astana could miss Tour of Beijing after Iglinskiy test


  • Cycling
  • Thursday, 02 Oct 2014

PARIS (Reuters) - Astana face the prospect of suspending themselves from racing on Thursday after their rider Maxim Iglinskiy failed a test for the banned blood-booster erythropoietin (EPO).

The Kazakh-funded team of Tour de France winner Vincenzo Nibali provisionally suspended Iglinskiy after the International Cycling Union (UCI) ruled late on Wednesday that the Kazakh had failed an EPO test on Aug. 1.

Win a prize this Mother's Day by subscribing to our annual plan now! T&C applies.

Monthly Plan

RM13.90/month

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
   

Next In Cycling

Cycling-Merlier sprints to Giro stage three win, Pogacar still in pink
Motorcycling-New MotoGP rules applicable from 2027 seek to make races safer
Young riders’ fine outing in Australia a good sign for the future
Hafidz rides to glory at third edition of L’Etape Malaysia
MNCF: Going for top prize in Paris a realistic target
Cycling-Pogacar powers into Maglia Rosa with Giro stage win
Cycling-Narvaez outsprints Pogacar to win Giro d'Italia stage one
Izzah eager to ride on WX-R Vorteq bike at Paris
Olympic-bound cyclists to gauge standings against Japanese rivals
Upset win for Ridwan

Others Also Read